Clinical trial recruitment of people who speak languages other than English: a Children’s Oncology Group report
JNCI Cancer Spectrum · 01.07.2024 · 8 (4)
DOI: 10.1093/jncics/pkae047 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 18.06.2024. Verfasst von Melissa P Beauchemin und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Research and Scholarship, Columbia University School of Nursing, New York, NY, USA. Hauptthemen laut MEDLINE: Patient Selection, Clinical Trials as Topic, Language, Communication Barriers. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NCI NIH HHS, NCTN Operations Center.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Persons who speak languages other than English are underrepresented in clinical trials, likely in part because of inadequate multilevel resources. We conducted a survey of institutions affiliated with the Children’s Oncology Group (COG) to characterize current research recruitment practices and resources regarding translation and interpretation services.
Methods
In October 2022, a 20-item survey was distributed electronically to institutions affiliated with COG to assess consent practices and resources for recruiting participants who speak languages other than English to COG trials. Descriptive statistics were used to summarize responses; responses were compared by institution size and type as well as respondent role.
Results
The survey was sent to 230 institutions, and the response rate was 60% (n = 139). In total, 60% (n = 83) of those respondents had access to short-form consent forms. Full consent form translation was required at 50% of institutions, and 12% of institutional review boards restricted use of centrally translated consent forms. Forty-six percent (n = 64) of institutions reported insufficient funding to support translation costs; 19% (n = 26) had access to no-cost translation services. Forty-four percent (n = 61) were required to use in-person interpreters for consent discussions; the most frequently cited barrier (56%) to obtaining consent was lack of available in-person interpreters. Forty-seven percent (n = 65) reported that recruiting persons who speak languages other than English to clinical trials was somewhat or very difficult.
Conclusions
Institutions affiliated with COG face resource-specific challenges that impede recruitment of participants who speak languages other than English for clinical trials. These findings indicate an urgent need to identify strategies aimed at reducing recruitment barriers to ensure equitable access to clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Research and Scholarship, Columbia University School of Nursing, New York, NY, USA.
- Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
- Children's Hospital of Philadelphia, Division of Oncology, Philadelphia, PA, USA.
- School of Nursing and Linberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Pediatric Oncology, Wake Forest University Health Sciences, Winston Salem, NC, USA.
- University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
ORCID-Profile: Melissa P Beauchemin, Sheila J Santacroce, Joanna M Robles, Jenny Ruiz, Anurekha G Hall, Justine M Kahn, Manuela Orjuela-Grimm, Grace C Hillyer, Wendy Pelletier, Raul Montiel-Esparza, Lindsay J Blazin, Cassie Kline, Alix E Seif, Lena E Winestone
Förderung
- NCATS NIH HHS
- NCI NIH HHS
- NCTN Operations Center
- COG NCI Community Oncology Research Program Research Base
Zitieren
APA
Beauchemin, M. P., Ortega, M., Santacroce, S. J., Robles, J. M., Ruiz, J., Hall, A. G., Kahn, J. M., Fu, C., Orjuela-Grimm, M., Hillyer, G. C., Solomon, S., Pelletier, W., Montiel-Esparza, R., Blazin, L. J., Kline, C., Seif, A. E., Aristizabal, P., Winestone, L. E., & Velez, M. C. (2024). Clinical trial recruitment of people who speak languages other than English: a Children’s Oncology Group report. JNCI Cancer Spectrum, 8(4). https://doi.org/10.1093/jncics/pkae047
Vancouver
Beauchemin MP, Ortega M, Santacroce SJ, Robles JM, Ruiz J, Hall AG, et al. Clinical trial recruitment of people who speak languages other than English: a Children’s Oncology Group report. JNCI Cancer Spectrum. 2024;8(4). doi:10.1093/jncics/pkae047
BibTeX
@article{Beauchemin2024,
author = {Beauchemin, Melissa P and Ortega, Maria and Santacroce, Sheila J and Robles, Joanna M and Ruiz, Jenny and Hall, Anurekha G and Kahn, Justine M and Fu, Cecilia and Orjuela-Grimm, Manuela and Hillyer, Grace C and Solomon, Samrawit and Pelletier, Wendy and Montiel-Esparza, Raul and Blazin, Lindsay J and Kline, Cassie and Seif, Alix E and Aristizabal, Paula and Winestone, Lena E and Velez, Maria C},
title = {Clinical trial recruitment of people who speak languages other than English: a Children’s Oncology Group report},
journal = {JNCI Cancer Spectrum},
year = {2024},
volume = {8},
number = {4},
doi = {10.1093/jncics/pkae047}
}
EUVIMED